FDA Approves a Second Alzheimer's Drug That Can Modestly Slow Disease

WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.